OCT market to hit $800 million by 2012

Article

By 2012 the market for optical coherence tomography (OCT) is predicted to hit the $800 million mark.

By 2012 the market for optical coherence tomography (OCT) is predicted to hit the $800 million mark, according to a recent market research report.

The report, "Optical Coherence Tomography - Technology, markets and applications: 2008-2021", from the publishers of BioOptics World quantifies this rapidly growing market for the first time. Currently the global market for OCT systems is around $200 million and is growing at an annual rate of 34%.

It is expected that the first commercial application of OCT, ophthalmology, will remain the dominant application until 2012, however, new applications and products are beginning to emerge in cardiology, dentistry, cancer detection, glucose monitoring and dermatology. In particular, commercial activity for OCT in intravascular imaging has been gaining momentum over the past 12 months.

Much of this recent activity in the market is being driven by a shift from time-domain to Fourier-domain OCT. While similar, Fourier-domain systems offer twice the resolution and 50 to 100 times the image-acquisition speed. Furthermore, because the Fourier-domain technique is not protected under tightly held patents, more companies are able to develop or market products using the technology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.